Anticoagulation: Difference between revisions

Latest revision as of 05:55, 25 January 2008

Redirect to:

@@ Line 1: / Line 1: @@
-{{subpages}}
+#redirect [[Anticoagulant]]
-{{editintro}}
-==Adverse effects==
-Patients aged 80 years or more may be especially susceptible to bleeding complications with a rate of 13 bleeds per 100 person-years.<ref name="pmid17515465">{{cite journal |author=Hylek EM, Evans-Molina C, Shea C, Henault LE, Regan S |title=Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation |journal=Circulation |volume=115 |issue=21 |pages=2689-96 |year=2007 |pmid=17515465 |doi=10.1161/CIRCULATIONAHA.106.653048}}PMID 17515465</ref>
-Patients with cancer are more likely to have bleeding complications, especially if they have metastatic cancer.<ref name="pmid12393647">{{cite journal |author=Prandoni P, Lensing AW, Piccioli A, ''et al'' |title=Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis |journal=Blood |volume=100 |issue=10 |pages=3484–8 |year=2002 |pmid=12393647 |doi=10.1182/blood-2002-01-0108}}</ref>
-==References==
-<references/>
-==See also==
-* [[Anticoagulant]]
-==External links==
-[http://www.chestjournal.org/content/vol126/3_suppl/ The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence-Based Guidelines]
-[[Category:CZ Live]] [[Category:Health Sciences Workgroup]]